Serum hemojuvelin and hepcidin levels in chronic kidney disease

American Journal of Nephrology

Volumn 35, Issue 3, 2012, Pages 295-304

  Rumjon, Adam ^a   Sarafidis, Pantelis ^a   Brincat, Stephan ^a   Musto, Rebecca ^a   Malyszko, Jolanta ^c   Bansal, Sukhvinder S ^b   Macdougall, Iain C ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Ferritin; Hemodialysis; Hemojuvelin; Hepcidin; Kidney transplant

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEMOGLOBIN; HEMOJUVELIN; HEPCIDIN; INTERLEUKIN 6;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; FERRITIN BLOOD LEVEL; GRAFT RECIPIENT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; ANTIMICROBIAL CATIONIC PEPTIDES; CASE-CONTROL STUDIES; FEMALE; FERRITINS; GPI-LINKED PROTEINS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84857755617     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000336528     Document Type: Article

References (25)

1. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, Kaplan J: Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2093. (Pubitemid 40007660)
2. Ganz T: Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003;102:783-788.
3. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T: IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113:1271-1276. (Pubitemid 39069926)
4. Nicolas G, Chauvet C, Viatte L, Danan JL, Bigard X, Devaux I, Beaumont C, Kahn A, Vaulont S: The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 2002;110:1037-1044.
5. Nemeth E, Valore EV, Territo M, Schiller G, Lichtenstein A, Ganz T: Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101:2461-2463. (Pubitemid 36857598)
6. Pasricha SR, McQuilten Z, Westerman M, Keller A, Nemeth E, Ganz T, Wood E: Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors. Haematologica 2011;96:1099-1105.
7. Swinkels DW, Wetzels JF: Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant 2008;23:2450-2453.
8. Macdougall IC, Malyszko J, Hider RC, Bansal SS: Current status of the measurement of blood hepcidin levels in chronic kidney disease. Clin J Am Soc Nephrol 2010;5:1681-1689.
9. Sasu BJ, Cooke KS, Arvedson TL, Plewa C, Ellison AR, Sheng J, Winters A, Juan T, Li H, Begley CG, Molineux G: Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation- induced anemia. Blood 2010;115:3616-3624.
10. Rodriguez Martinez A, Niemela O, Parkkila S: Hepatic and extrahepatic expression of the new iron regulatory protein hemojuvelin. Haematologica 2004;89:1441-1445. (Pubitemid 39643510)
11. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, Andres L, MacFarlane J, Sakellaropoulos N, Politou M, Nemeth E, Thompson J, Risler JK, Zaborowska C, Babakaiff R, Radomski CC, Pape TD, Davidas O, Christakis J, Brissot P, Lockitch G, Ganz T, Hayden MR, Goldberg YP: Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82. (Pubitemid 38056211)
12. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, Chung RT, Schneyer AL, Woolf CJ, Andrews NC, Lin HY: Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 2006;38:531-539.
13. Casanovas G, Mleczko-Sanecka K, Altamura S, Hentze MW, Muckenthaler MU: Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD. J Mol Med 2009;87:471-480.
14. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C: The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008;8:502-511.
15. Lin L, Goldberg YP, Ganz T: Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 2005;106:2884-2889. (Pubitemid 41510769)
16. Niederkofler V, Salie R, Arber S: Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005;115:2180-2186. (Pubitemid 41134159)
17. Brasse-Lagnel C, Poli M, Lesueur C, Grandchamp B, Lavoinne A, Beaumont C, Bekri S: Immunoassay for human serum hemojuvelin. Haematologica 2010;95:2031-2037.
18. Bansal SS, Abbate V, Bomford A, Halket JM, Macdougall IC, Thein SL, Hider RC: Quantitation of hepcidin in serum using ultrahigh- pressure liquid chromatography and a linear ion trap mass spectrometer. Rapid Commun Mass Spectrom 2010;24:1251-1259.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470. (Pubitemid 29135798)
20. Zhang AS, Anderson SA, Meyers KR, Hernandez C, Eisenstein RS, Enns CA: Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J Biol Chem 2007;282:12547-12556. (Pubitemid 47100643)
21. Krijt J, Vokurka M, Chang KT, Necas E: Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 2004;104:4308-4310. (Pubitemid 39620187)
22. Constante M, Wang D, Raymond VA, Bilodeau M, Santos MM: Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha. Am J Pathol 2007;170:497-504. (Pubitemid 47339387)
23. Chawla LS, Krishnan M: Causes and consequences of inflammation on anemia management in hemodialysis patients. Hemodial Int 2009;13:222-234.
24. Tomosugi N, Kawabata H, Wakatabe R, Higuchi M, Yamaya H, Umehara H, Ishikawa I: Detection of serum hepcidin in renal failure and inflammation by using proteinchip system. Blood 2006;108:1381-1387. (Pubitemid 44232041)
25. Silvestri L, Pagani A, Fazi C, Gerardi G, Levi S, Arosio P, Camaschella C: Defective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemochromatosis. Blood 2007;109:4503-4510. (Pubitemid 46743421)